The gene-editing technology known as CRISPR has attracted much excitement and investor interest with its potential to someday treat diseases by fixing faulty copies of genes. But recently, a different approach called RNA editing, which could offer advantages over CRISPR, has been gaining ground in academic labs and start-ups, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.
RNA editing uses an enzyme called ADAR to make precise edits to RNA, the shorter-lived cousin to DNA that acts as a blueprint for proteins. Researchers direct ADAR to specific RNAs with a guide sequence attached to the enzyme. Unlike CRISPR gene editing, the effects of RNA editing are reversible because cells are constantly making new copies of RNA. Therefore, RNA editing avoids the risks of permanent gene editing with CRISPR, writes Assistant Editor Ryan Cross, and could also be used to treat temporary conditions, such as pain or inflammation.
However, finding an easy way to control how ADAR makes its edits has been challenging. Researchers have tried chemically attaching ADAR to a guide RNA, adding an RNA-binding protein or even linking the catalytic portion of ADAR to the bacterial Cas9 enzyme used in CRISPR. However, these approaches require getting the modified enzymes into human cells. Some researchers are working on using human cells’ own ADAR for RNA editing, by introducing chemically modified guide RNAs that recruit the editing enzyme and direct it to specific RNAs. With researchers and investors becoming increasingly interested in this approach, RNA editing could someday give CRISPR a run for its money, Cross writes.
The article, “Watch out, CRISPR. The RNA editing race is on,” is freely available here.
Learn more: Interest in RNA editing heats up
The Latest on: RNA editing
via Google News
The Latest on: RNA editing
- CRISPR/Cas9 system is highly effective in treating metastatic cancerson November 20, 2020 at 8:12 am
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer.
- Revolutionary CRISPR-based genome editing system treatment destroys cancer cellson November 20, 2020 at 12:43 am
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer. The ...
- Like CRISPR, mystery gene editor began as a virus fighteron November 19, 2020 at 6:50 pm
On 5 November in Cell, one team described how a specific retron defends bacteria, triggering newly infected cells to self-destruct so the virus can't replicate and spread to others. The Cell paper “is ...
- CRISPR Technique Effectively Destroys Metastatic Cancer Cells in Living Animalon November 19, 2020 at 12:00 pm
Cas9 technology for cancer therapeutics has been hampered by low editing efficiency in tumors and potential toxicity of existing delivery systems. Scientists at Tel Aviv University describe a safe and ...
- CRISPR & Cas Genes Market Value to Reach US$ 4.23 Bn by 2027on November 18, 2020 at 6:23 pm
CRISPR technology is a modest yet influential tool for genome editing. It permits researchers to effortlessly modify DNA sequences and alter gene function. Its various budding applications comprise ...
- TAU researchers prove that the CRISPR genome editing system is very effective in treating metastatic cancerson November 18, 2020 at 4:00 pm
The novel CRISPR-based cancer treatment destroys cancer cells and increases life expectancy in brain and ovarian cancers.
- ElevateBio and AgBiome Announce LifeEDIT Will Join ElevateBio’s Portfolio of Innovative Cell and Gene Therapy Companieson November 16, 2020 at 4:33 am
ElevateBio and AgBiome Announce LifeEDIT Will Join ElevateBio’s Portfolio of Innovative Cell and Gene Therapy Companies ...
- Microbes’ mystery DNA helps defeat viruses—and has genome-editing potentialon November 12, 2020 at 7:32 am
Sparking thoughts of CRISPR’s beginnings, the genetic elements called retrons can only edit single-cell organisms so far ...
- CRISPR Pioneer Zhang Details New Editing System Downstream From DNAon October 24, 2020 at 5:01 pm
[Updated 10/25/17 4:26pm ET] Researchers at the Broad Institute have adapted the CRISPR-Cas gene editing system so that it can change the sequence of RNA, rather than edit DNA. RNA transports ...
- Chun Liangon August 17, 2020 at 1:12 am
CRISPR-based DNA and RNA editing: target design and specificity, genome-wide detection of CRISPRs in prokaryotic genomes, DNA methylation and its role in tissue regeneration, RNA-Seq based ...
via Bing News